Eddy Pharmaceuticals announced that the company plans to use its own funds to repurchase shares through centralized bidding transactions. The repurchase amount is not less than 10 million yuan, no more than 20 million yuan, and the repurchase price is no more than 22.39 yuan/share. According to the upper limit, the corresponding repurchase of 446,600 shares to 893,200 shares is estimated, accounting for 0.11% to 0.21% of the total share capital. Shares will be repurchased for employee stock ownership plans or share incentives. The repurchase period is within 12 months from the date of review and approval by the board of directors. The company's directors, executives, controlling shareholders, actual controllers and shareholders holding 5% or more of the shares have no plans to reduce their holdings for the next 6 months.

Eddy Pharmaceuticals announced that the company plans to use its own funds to repurchase shares through centralized bidding transactions. The repurchase amount is not less than 10 million yuan, no more than 20 million yuan, and the repurchase price is no more than 22.39 yuan/share. According to the upper limit, the corresponding repurchase of 446,600 shares to 893,200 shares is estimated, accounting for 0.11% to 0.21% of the total share capital. Shares will be repurchased for employee stock ownership plans or share incentives. The repurchase period is within 12 months from the date of review and approval by the board of directors. The company's directors, executives, controlling shareholders, actual controllers and shareholders holding 5% or more of the shares have no plans to reduce their holdings for the next 6 months.